Occidental Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$485K Buy
2,163
+464
+27% +$116K 0.06% 166
2025
Q4
$409K Buy
1,699
+49
+3% +$12.5K 0.05% 176
2025
Q3
$452K Buy
1,650
+80
+5% +$21.9K 0.06% 171
2025
Q2
$405K Sell
1,570
-1
-0.1% -$239 0.06% 166
2025
Q1
$352K Buy
1,571
+118
+8% +$27.5K 0.05% 170
2024
Q4
$332K Buy
+1,453
New +$350K 0.05% 157
2022
Q1
Sell
-800
Closed -$208K 212
2021
Q4
$208K Hold
800
0.05% 199
2021
Q3
$211K Buy
+800
New +$219K 0.05% 197

Other funds holding RMD

Occidental Asset Management's RMD Position: Q1 2026 in Review

Occidental Asset Management increased its ResMed (RMD) stake by 27% in Q1 2026, buying an estimated $116K and bringing the position to 2,163 shares worth $485K. The position accounts for 0.06% of the portfolio, ranked #166.

Occidental Asset Management first reported a position in RMD in Q3 2021 and has held it in 8 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Occidental Asset Management held 2,163 shares of ResMed worth $485K as of Q1 2026.
  • Occidental Asset Management bought 464 ResMed shares in Q1 2026, an estimated $116K.
  • ResMed made up 0.06% of Occidental Asset Management's portfolio in Q1 2026, its #166 holding.
  • Occidental Asset Management first reported a position in ResMed in Q3 2021 and has held it in 8 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.